Treatment of Cardiovascular Disease With Low Dose Rivaroxaban in Advanced Chronic Kidney Disease

Clinical trial NCT03969953 · COMPLETED

Trial details

NCT number: NCT03969953
Sponsor: The George Institute
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Chronic Kidney Diseases Dialysis-dependent Kidney Failure Cardiovascular Disease

Start date: 2021-01-18
Primary completion: 2025-10-30
Enrollment: 1753

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.